Skip to main content
Sameek Roychowdhury, MD, Oncology, Columbus, OH

SameekRoychowdhuryMDPhD

Oncology Columbus, OH

Associate Professor, Internal Medicine, Ohio State University College of Medicine

Dr. Roychowdhury is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Roychowdhury's full profile

Already have an account?

  • Office

    460 W 10th Ave
    Columbus, OH 43210
    Phone+1 614-293-6529
    Fax+1 614-293-9469

Summary

  • Dr. Sameek Roychowdhury is an oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from Ohio State University College of Medicine and has been in practice 11 years. He is experienced in hematologic oncology.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 2006 - 2008
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2006

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2012 - 2026
  • MI State Medical License
    MI State Medical License 2006 - 2013
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Blood Test for Cancer Now Available, but Is It Ready for Prime Time?
    Blood Test for Cancer Now Available, but Is It Ready for Prime Time?August 16th, 2022
  • 'Autopsy Trial' Allows Researchers to Explore How Cancer Patients' Disease Overcomes Treatment
    'Autopsy Trial' Allows Researchers to Explore How Cancer Patients' Disease Overcomes TreatmentSeptember 29th, 2021
  • Fibroblast Growth Factor Receptors in Cancer: Genetic Alterations, Diagnostics, Therapeutic Targets and Mechanisms of Resistance
    Fibroblast Growth Factor Receptors in Cancer: Genetic Alterations, Diagnostics, Therapeutic Targets and Mechanisms of ResistanceDecember 3rd, 2020
  • Join now to see all

Professional Memberships